161
Participants
Start Date
April 30, 2011
Primary Completion Date
September 30, 2011
Study Completion Date
December 31, 2011
NER1006
Single evening dose of 750mL solution containing 100g PEG3350 plus 6g sodium sulphate. Single morning dose containing 40g PEG3350, 33.9g sodium ascorbate, 20.1g ascorbic acid.
NER1006
Single evening dose of 750mL solution containing 100g PEG3350 plus 9g sodium sulphate. Single morning dose containing 40g PEG3350, 33.9g sodium ascorbate, 20.1g ascorbic acid.
NER1006
Single evening dose of 750mL solution containing 75g PEG3350 plus 5.6g sodium sulphate. Single morning dose containing 40g PEG3350, 33.9g sodium ascorbate, 20.1g ascorbic acid.
Moviprep
Reconstituted and administered in accordance with recommended split dose intake: one litre in the evening, one litre the following morning.
NER1006
Single evening dose containing formulation selected from Part A of study. Single morning dose containing 40g PEG3350 and 56.6g sodium ascorbate.
NER1006
Single evening dose containing formulation selected from Part A of study. Single morning dose containing 40g PEG3350, 33.9g sodium ascorbate and 21.4g magnesium ascorbate.
NER1006
Single evening dose containing formulation selected from Part A of study. Single morning dose containing 40g PEG3350, 6g sodium sulphate and 33.9g sodium ascorbate.
NER1006
Single evening dose containing formulation selected from Part A of study. Single morning dose containing 29g PEG3350 and 4.8g sulphate and 23.3g ascorbic acid.
Pierrel Research HP-RO-SRL, Timișoara
Pierrel Research HP-RO-SRL, Timișoara
Lead Sponsor
Pierrel Research Europe GmbH
INDUSTRY
Norgine
INDUSTRY